Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.730
-0.030 (-1.70%)
At close: Aug 28, 2026, 4:00 PM EDT
1.710
-0.020 (-1.16%)
After-hours: Aug 28, 2026, 6:58 PM EDT
ZYBT Market Cap
ZYBT has a market cap or net worth of $81.99 million as of August 28, 2026. Its market cap has decreased by -80.25% in one year.
Market Cap
81.99M
Enterprise Value
85.30M
1-Year Change
-80.25%
Ranking
Category
Stock Price
$1.73
ChartMarket Cap Chart
Since the IPO on January 7, 2025, ZYBT's market cap has decreased from $188.67M to $81.99M, a decrease of -56.54%. That is a compound annual growth rate of -39.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 81.99M | 50.43% |
| Dec 31, 2025 | 54.50M | -71.11% |
| Jan 7, 2025 | 188.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lifecore Biomedical | 171.85M |
| Organigram Global | 170.60M |
| ADC Therapeutics | 142.99M |
| Cumberland Pharmaceuticals | 129.60M |
| BGM Group | 116.86M |
| Citius Oncology | 83.58M |
| Talphera | 63.84M |
| InterCure | 63.11M |